nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—Tumour lysis syndrome—Thalidomide—leprosy	0.0404	0.0441	CcSEcCtD
Clofarabine—DCK—Menadione—Thalidomide—leprosy	0.0389	1	CbGdCrCtD
Clofarabine—Septic shock—Thalidomide—leprosy	0.0371	0.0406	CcSEcCtD
Clofarabine—Pericarditis—Thalidomide—leprosy	0.0259	0.0283	CcSEcCtD
Clofarabine—Lymphopenia—Thalidomide—leprosy	0.0219	0.0239	CcSEcCtD
Clofarabine—Skin exfoliation—Dapsone—leprosy	0.0209	0.0228	CcSEcCtD
Clofarabine—Febrile neutropenia—Thalidomide—leprosy	0.0186	0.0204	CcSEcCtD
Clofarabine—Oral candidiasis—Thalidomide—leprosy	0.0177	0.0193	CcSEcCtD
Clofarabine—Pleural effusion—Thalidomide—leprosy	0.0146	0.016	CcSEcCtD
Clofarabine—Influenza—Dapsone—leprosy	0.0137	0.015	CcSEcCtD
Clofarabine—Petechiae—Thalidomide—leprosy	0.0136	0.0149	CcSEcCtD
Clofarabine—Pancreatitis—Dapsone—leprosy	0.0135	0.0147	CcSEcCtD
Clofarabine—Viral infection—Thalidomide—leprosy	0.0124	0.0136	CcSEcCtD
Clofarabine—Bone disorder—Thalidomide—leprosy	0.0124	0.0136	CcSEcCtD
Clofarabine—Cellulitis—Thalidomide—leprosy	0.0123	0.0135	CcSEcCtD
Clofarabine—Hyperbilirubinaemia—Thalidomide—leprosy	0.0123	0.0135	CcSEcCtD
Clofarabine—Herpes simplex—Thalidomide—leprosy	0.0122	0.0133	CcSEcCtD
Clofarabine—Hyperuricaemia—Thalidomide—leprosy	0.0121	0.0132	CcSEcCtD
Clofarabine—Neuropathy peripheral—Dapsone—leprosy	0.012	0.0131	CcSEcCtD
Clofarabine—Creatinine increased—Thalidomide—leprosy	0.0118	0.0129	CcSEcCtD
Clofarabine—Hearing impaired—Thalidomide—leprosy	0.0118	0.0129	CcSEcCtD
Clofarabine—Bone pain—Thalidomide—leprosy	0.0117	0.0128	CcSEcCtD
Clofarabine—Sinusitis—Dapsone—leprosy	0.0115	0.0126	CcSEcCtD
Clofarabine—Blood uric acid increased—Thalidomide—leprosy	0.0114	0.0125	CcSEcCtD
Clofarabine—Hepatocellular injury—Thalidomide—leprosy	0.0112	0.0123	CcSEcCtD
Clofarabine—Colitis—Thalidomide—leprosy	0.0108	0.0118	CcSEcCtD
Clofarabine—Candida infection—Thalidomide—leprosy	0.0107	0.0117	CcSEcCtD
Clofarabine—Skin exfoliation—Thalidomide—leprosy	0.0107	0.0117	CcSEcCtD
Clofarabine—Rash maculo-papular—Thalidomide—leprosy	0.0102	0.0111	CcSEcCtD
Clofarabine—Pulmonary oedema—Thalidomide—leprosy	0.00998	0.0109	CcSEcCtD
Clofarabine—Sepsis—Thalidomide—leprosy	0.00973	0.0106	CcSEcCtD
Clofarabine—Erythema—Dapsone—leprosy	0.00958	0.0105	CcSEcCtD
Clofarabine—Deafness—Thalidomide—leprosy	0.0091	0.00994	CcSEcCtD
Clofarabine—Renal failure acute—Thalidomide—leprosy	0.00882	0.00963	CcSEcCtD
Clofarabine—Cough—Dapsone—leprosy	0.00836	0.00913	CcSEcCtD
Clofarabine—Lethargy—Thalidomide—leprosy	0.00831	0.00908	CcSEcCtD
Clofarabine—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00814	0.00889	CcSEcCtD
Clofarabine—Pain in extremity—Thalidomide—leprosy	0.00814	0.00889	CcSEcCtD
Clofarabine—Tachycardia—Dapsone—leprosy	0.00763	0.00833	CcSEcCtD
Clofarabine—Blood creatinine increased—Thalidomide—leprosy	0.00763	0.00833	CcSEcCtD
Clofarabine—Dehydration—Thalidomide—leprosy	0.00757	0.00827	CcSEcCtD
Clofarabine—Dry skin—Thalidomide—leprosy	0.00746	0.00815	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00733	0.00801	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00733	0.00801	CcSEcCtD
Clofarabine—Alanine aminotransferase increased—Thalidomide—leprosy	0.00718	0.00784	CcSEcCtD
Clofarabine—Influenza—Thalidomide—leprosy	0.00704	0.00769	CcSEcCtD
Clofarabine—Pancreatitis—Thalidomide—leprosy	0.0069	0.00754	CcSEcCtD
Clofarabine—Pancytopenia—Thalidomide—leprosy	0.00668	0.0073	CcSEcCtD
Clofarabine—Neutropenia—Thalidomide—leprosy	0.00658	0.00719	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Thalidomide—leprosy	0.00654	0.00714	CcSEcCtD
Clofarabine—Gastrointestinal pain—Dapsone—leprosy	0.00639	0.00698	CcSEcCtD
Clofarabine—Weight decreased—Thalidomide—leprosy	0.00637	0.00695	CcSEcCtD
Clofarabine—Pneumonia—Thalidomide—leprosy	0.00631	0.00689	CcSEcCtD
Clofarabine—Infestation NOS—Thalidomide—leprosy	0.00627	0.00685	CcSEcCtD
Clofarabine—Infestation—Thalidomide—leprosy	0.00627	0.00685	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00622	0.00679	CcSEcCtD
Clofarabine—Abdominal pain—Dapsone—leprosy	0.00618	0.00675	CcSEcCtD
Clofarabine—Body temperature increased—Dapsone—leprosy	0.00618	0.00675	CcSEcCtD
Clofarabine—Renal failure—Thalidomide—leprosy	0.00617	0.00674	CcSEcCtD
Clofarabine—Neuropathy peripheral—Thalidomide—leprosy	0.00615	0.00672	CcSEcCtD
Clofarabine—Stomatitis—Thalidomide—leprosy	0.00612	0.00668	CcSEcCtD
Clofarabine—Haematuria—Thalidomide—leprosy	0.00598	0.00653	CcSEcCtD
Clofarabine—Epistaxis—Thalidomide—leprosy	0.00592	0.00646	CcSEcCtD
Clofarabine—Sinusitis—Thalidomide—leprosy	0.00589	0.00643	CcSEcCtD
Clofarabine—Urinary tract disorder—Thalidomide—leprosy	0.00556	0.00608	CcSEcCtD
Clofarabine—Oedema peripheral—Thalidomide—leprosy	0.00555	0.00606	CcSEcCtD
Clofarabine—Urethral disorder—Thalidomide—leprosy	0.00552	0.00603	CcSEcCtD
Clofarabine—Erythema multiforme—Thalidomide—leprosy	0.00533	0.00582	CcSEcCtD
Clofarabine—Cardiac disorder—Thalidomide—leprosy	0.00523	0.00571	CcSEcCtD
Clofarabine—Angiopathy—Thalidomide—leprosy	0.00511	0.00558	CcSEcCtD
Clofarabine—Immune system disorder—Thalidomide—leprosy	0.00509	0.00556	CcSEcCtD
Clofarabine—Mediastinal disorder—Thalidomide—leprosy	0.00508	0.00554	CcSEcCtD
Clofarabine—Chills—Thalidomide—leprosy	0.00505	0.00552	CcSEcCtD
Clofarabine—Alopecia—Thalidomide—leprosy	0.00498	0.00544	CcSEcCtD
Clofarabine—Vomiting—Dapsone—leprosy	0.00497	0.00543	CcSEcCtD
Clofarabine—Mental disorder—Thalidomide—leprosy	0.00494	0.00539	CcSEcCtD
Clofarabine—Malnutrition—Thalidomide—leprosy	0.0049	0.00536	CcSEcCtD
Clofarabine—Headache—Dapsone—leprosy	0.0049	0.00535	CcSEcCtD
Clofarabine—RRM2—skin of body—leprosy	0.00481	0.106	CbGeAlD
Clofarabine—Back pain—Thalidomide—leprosy	0.00474	0.00518	CcSEcCtD
Clofarabine—Nausea—Dapsone—leprosy	0.00464	0.00507	CcSEcCtD
Clofarabine—RRM1—eye—leprosy	0.0046	0.101	CbGeAlD
Clofarabine—Tremor—Thalidomide—leprosy	0.00459	0.00502	CcSEcCtD
Clofarabine—Anaemia—Thalidomide—leprosy	0.00453	0.00495	CcSEcCtD
Clofarabine—Agitation—Thalidomide—leprosy	0.00451	0.00492	CcSEcCtD
Clofarabine—Leukopenia—Thalidomide—leprosy	0.00439	0.00479	CcSEcCtD
Clofarabine—Cough—Thalidomide—leprosy	0.00428	0.00467	CcSEcCtD
Clofarabine—Hypertension—Thalidomide—leprosy	0.00423	0.00462	CcSEcCtD
Clofarabine—Arthralgia—Thalidomide—leprosy	0.00417	0.00456	CcSEcCtD
Clofarabine—Myalgia—Thalidomide—leprosy	0.00417	0.00456	CcSEcCtD
Clofarabine—Anxiety—Thalidomide—leprosy	0.00416	0.00454	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00415	0.00453	CcSEcCtD
Clofarabine—Oedema—Thalidomide—leprosy	0.004	0.00437	CcSEcCtD
Clofarabine—RRM1—skin of body—leprosy	0.004	0.088	CbGeAlD
Clofarabine—Infection—Thalidomide—leprosy	0.00398	0.00434	CcSEcCtD
Clofarabine—Nervous system disorder—Thalidomide—leprosy	0.00392	0.00429	CcSEcCtD
Clofarabine—Thrombocytopenia—Thalidomide—leprosy	0.00392	0.00428	CcSEcCtD
Clofarabine—Tachycardia—Thalidomide—leprosy	0.00391	0.00427	CcSEcCtD
Clofarabine—Skin disorder—Thalidomide—leprosy	0.00389	0.00425	CcSEcCtD
Clofarabine—Hyperhidrosis—Thalidomide—leprosy	0.00387	0.00423	CcSEcCtD
Clofarabine—POLA1—tendon—leprosy	0.00384	0.0844	CbGeAlD
Clofarabine—Anorexia—Thalidomide—leprosy	0.00381	0.00417	CcSEcCtD
Clofarabine—Hypotension—Thalidomide—leprosy	0.00374	0.00408	CcSEcCtD
Clofarabine—RRM2—tendon—leprosy	0.00366	0.0806	CbGeAlD
Clofarabine—Musculoskeletal discomfort—Thalidomide—leprosy	0.00365	0.00398	CcSEcCtD
Clofarabine—Paraesthesia—Thalidomide—leprosy	0.00359	0.00392	CcSEcCtD
Clofarabine—Dyspnoea—Thalidomide—leprosy	0.00357	0.0039	CcSEcCtD
Clofarabine—Somnolence—Thalidomide—leprosy	0.00356	0.00389	CcSEcCtD
Clofarabine—Decreased appetite—Thalidomide—leprosy	0.00348	0.0038	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Thalidomide—leprosy	0.00346	0.00377	CcSEcCtD
Clofarabine—Fatigue—Thalidomide—leprosy	0.00345	0.00377	CcSEcCtD
Clofarabine—Pain—Thalidomide—leprosy	0.00342	0.00374	CcSEcCtD
Clofarabine—Feeling abnormal—Thalidomide—leprosy	0.0033	0.0036	CcSEcCtD
Clofarabine—Gastrointestinal pain—Thalidomide—leprosy	0.00327	0.00357	CcSEcCtD
Clofarabine—POLA1—testis—leprosy	0.00318	0.0699	CbGeAlD
Clofarabine—Abdominal pain—Thalidomide—leprosy	0.00316	0.00346	CcSEcCtD
Clofarabine—Body temperature increased—Thalidomide—leprosy	0.00316	0.00346	CcSEcCtD
Clofarabine—RRM1—tendon—leprosy	0.00304	0.067	CbGeAlD
Clofarabine—RRM2—testis—leprosy	0.00303	0.0667	CbGeAlD
Clofarabine—RRM2—nervous system—leprosy	0.00298	0.0655	CbGeAlD
Clofarabine—Hypersensitivity—Thalidomide—leprosy	0.00295	0.00322	CcSEcCtD
Clofarabine—Asthenia—Thalidomide—leprosy	0.00287	0.00314	CcSEcCtD
Clofarabine—Pruritus—Thalidomide—leprosy	0.00283	0.00309	CcSEcCtD
Clofarabine—Diarrhoea—Thalidomide—leprosy	0.00274	0.00299	CcSEcCtD
Clofarabine—Dizziness—Thalidomide—leprosy	0.00265	0.00289	CcSEcCtD
Clofarabine—Vomiting—Thalidomide—leprosy	0.00254	0.00278	CcSEcCtD
Clofarabine—Rash—Thalidomide—leprosy	0.00252	0.00276	CcSEcCtD
Clofarabine—Dermatitis—Thalidomide—leprosy	0.00252	0.00275	CcSEcCtD
Clofarabine—RRM1—testis—leprosy	0.00252	0.0554	CbGeAlD
Clofarabine—Headache—Thalidomide—leprosy	0.00251	0.00274	CcSEcCtD
Clofarabine—RRM1—nervous system—leprosy	0.00247	0.0544	CbGeAlD
Clofarabine—Nausea—Thalidomide—leprosy	0.00238	0.0026	CcSEcCtD
Clofarabine—DCK—tendon—leprosy	0.00236	0.052	CbGeAlD
Clofarabine—DCK—testis—leprosy	0.00196	0.0431	CbGeAlD
Clofarabine—DCK—nervous system—leprosy	0.00192	0.0423	CbGeAlD
Clofarabine—ABCG2—testis—leprosy	0.00109	0.024	CbGeAlD
